BOC Sciences to Update Screening Libraries for Drug Discovery

SHIRLEY, NY, UNITED STATES - Apr 23, 2019 - The New York- based chemical company BOC Sciences announces to upgrade its screening libraries for drug discovery efforts.

After this move, the screening libraries at BOC Sciences houses twenty-one libraries that can be used for drug discovery, drug target identification, laboratory drug screening, and many other drug related applications. Each library can be screened individually or used in conjunction with other libraries so as to maximize the chance of finding a hit. Also, it can be tailored to the requirements of the HTS project.

“Screening libraries takes a vital position in modern drug discovery. They can be used to help produce new pharmaceuticals or lead-based screening compounds, especially in today’s industry and academia circle where the demand for new therapeutic drugs is increasing,” says Mr. Barron Jones, the Marketing Chief of BOC Sciences. “Some of these libraries allow rapid identification of active compounds, antibodies or genes that regulate specific biomolecule pathways, which provides important implications for drug design and understanding of specific biochemical processes.”

The following five screening libraries are available at BOC Sciences.

• High Throughput Screening Libraries

High throughput screening is merited for its ability to enable researchers to rapidly perform millions of chemical, genetic, or pharmacological tests by using robotic technology, liquid processing devices, data processing/control software and sensitive probes, and then successfully identify active compounds, antibodies, or genes that regulate specific biological pathways and thus could be potential therapeutic molecules.

• Fragment Libraries

Fragment-based drug design (FBDD) is becoming an alternative method for high-throughput screening in the drug discovery efforts. After cutting the known drug molecules into pieces, some of these molecular fragments may still inherit all or part of the original pharmacological properties of these active molecules, which can be further converted into a better drug through structural optimization.

• Activity-based Libraries

We use this type of library to classify and collect biologically active molecules into different databases according to their different potential applications, for example, anti-inflammatory databases and anti-cancer databases.

• Custom Libraries

By custom libraries, customers can select diverse compounds from BOC Sciences and specify desired quantities to create a unique compound library to meet exact screening requirements.  

• Library Design

The focus of library design has transferred toward designing libraries based on numbers of properties simultaneously, for example, diversity and drug-like physicochemical properties. These libraries can produce HTS hits with properties that make them suitable to be taken forward into medicinal chemistry.

BOC Sciences’ libraries have diverse biological-and pharmacological-functioning compounds that can be used as high content of screening materials. Please visit https://www.solutions.bocsci.com/screening-libraries.htm to know more.

About BOC Sciences

Dedicated to become a trust-worthy brand, BOC Sciences strives to offer strategies and solutions to assist in the resolution of the industry’s most pressing drug development issues. To this end, it provides comprehensive medicinal chemistry services, custom synthesis, analysis/purification, formulation services for pharmaceutical companies engaged in drug discovery and research.